B7 co-stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination

European Journal of Immunology

Volumn 30, Issue 9, 2000, Pages 2650-2659

  Santra, Sampa ^a   Barouch, Dan H ^a   Sharpe, Arlene H ^b   Letvin, Norman L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Co stimulatory molecule; Cytotoxic T lymphocyte; Vaccination

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GLYCOPROTEIN GP 120; RECOMBINANT DNA; RECOMBINANT PROTEIN; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION;

AIDS VACCINES; ANIMAL; ANTIGENS, CD; ANTIGENS, CD80; FEMALE; HIV ENVELOPE PROTEIN GP120; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC; VACCINIA VIRUS;

EID: 0033829862     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200009)30:9<2650::AID-IMMU2650>3.0.CO;2-K     Document Type: Article

References (32)

1. Clonal expansion versus functional clonal activation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy
2. The role of the CD28 receptor during T cell responses to antigen
3. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
4. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells
5. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
6. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice
7. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
8. B70 antigen is a second ligand for CTLA-4 and CD28
9. CTLA-4 is a second receptor for the B cell activation antigen B7
10. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines
11. CTLA-4 can function as a negative regulator of T cell activation
12. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan destruction, revealing critical negative regulatory role of CTLA-4
13. Differential T cell costimulatory requirements in CD28-deficient mice
14. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen
15. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells
16. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release
17. Neisserial porins induce B lymphocytes to express co-stimulatory B7-2 molecules and to proliferate
18. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
19. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL
20. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
21. + CTL generation in the host response to vesicular stomatitis virus
22. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation
23. Humoral and cellular immunities elicited by HIV-1 DNA vaccination
24. Heterologous and homologous protection against influenza A by DNA vaccination: Optimization of DNA vectors
25. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA-4
26. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
27. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen
28. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes
29. Costimulation provided by DNA immunization enhances antitumor immunity
30. Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells
31. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration
32. Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant